Zhijuan Lin, Long Liu, Manman Deng, Xingxing Yu, Yan Hong, Hua Wang, Keshu Zhou, Shaojie Wu, Ting-Bo Liu, Na Qin, Rui Su, Zhifeng Li, Bing Xu. "Zanubrutinib plus obinutuzumab induces promising efficacy and a manageable safety profile in previously untreated high-tumor-burden follicular lymphoma." Blood, 2025. doi:10.1182/blood-2025-1818